The Valley Desk

Clinical trial reportClinical colorectal cancerPublished

Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Clinical colorectal cancer
Published
Subject terms
Humans; Colorectal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Male; Microsatellite Instability; Antibodies, Monoclonal, Humanized; Bevacizumab
PubMed ID
41826077
Added to directory
Source checked

Report a correction or request removal